Also trades as: BETR.CN (CNQ) · $vol 0M
BETRF OTC
BetterLife Pharma Inc.
1W: -20.5%
1M: -7.2%
3M: +47.3%
YTD: +569.2%
1Y: +252.4%
3Y: +212.7%
5Y: -17.7%
$0.19
-0.01 (-5.02%)
Weekly Expected Move ±19.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$626K
+69.0% ▲
Capital Expenditures
$5
+0.0% ▲
5Y CAGR: -85.9%
Free Cash Flow
-$626K
+69.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$5K
+116.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$12M | -$9M | -$3M | -$4M | -$2M |
| Depreciation & Amort. | $18K | $18K | $0 | $0 | $0 |
| Stock-Based Comp. | $1M | $951K | $500K | $2M | $170K |
| Change in Working Capital | -$1M | $3M | $322K | $753K | $1M |
| Other Non-Cash Items | $972K | $3M | -$396K | -$1M | -$498K |
| Operating Cash Flow | -$11M | -$2M | -$2M | -$2M | -$626K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$19K | $165K | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$250K | $0 | $300K | $1M | $407K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $43K | $503K | $2M | $63K | $3 |
| Financing Cash Flow | $11M | $1M | $3M | $2M | $630K |
| Net Change in Cash | $19K | -$165K | $29K | -$29K | $5K |
| Cash End of Period | $174K | $8K | $37K | $8K | $13K |
| Free Cash Flow | -$11M | -$2M | -$2M | -$2M | -$626K |